Jan 21 (Reuters) - Aap Implantate AG AAQG.DE :
* DGAP-NEWS: FY/18: SALES WITH DOUBLE-DIGIT GROWTH IN
GERMANY AND
INTERNATIONAL, NORTH AMERICA BELOW EXPECTATIONS - MILESTONES IN
SILVER COATING TECHNOLOGY; FOR FY/19 DOUBLE-DIGIT SALES INCREASE
PLANNED AND START OF HUMAN CLINICAL STUDY TARGETED
* FY/2018 SALES OF EUR 10.8 MILLION
* AROUND 20% - 40% SALES GROWTH AND EARNINGS IMPROVEMENT
PLANNED
FOR FY/2019
* FORECAST FOR SALES OF EUR 13.0 MILLION TO EUR 15.0 MILLION
IN
2019
* SEES FY 2019 EBITDA OF EUR -4.4 MILLION TO EUR -2.8
MILLION
* FOR Q1 OF 2019 MANAGEMENT BOARD ANTICIPATES SALES OF EUR
2.0
MILLION TO EUR 3.0 MILLION
* FOR Q1 OF 2019 MANAGEMENT BOARD EBITDA IN RANGE OF EUR
-1.8
MILLION TO EUR -1.2 MILLION
Source text for Eikon: ID:nEQb316Zxa
Further company coverage: AAQG.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))